AssurX provides comprehensive solutions for compliance with 21 CFR 820, ensuring medical device manufacturers meet FDA’s Quality System Regulation requirements. Our platform enhances quality processes, streamlines documentation, and supports operational excellence to maintain compliance.
The U.S. Food and Drug Administration (FDA) has been ramping up on-site inspect [...]
In January 2024, the U.S. Food and Drug Administration (FDA) issued a final rul [...]
In December 2023, the U.S. Food and Drug Administration (FDA) expects to issue i [...]
This article is part one of a two-part series focused on GMP quality audit mana [...]
Technology, Politics, Climate, and the Coronavirus will Drive Maturation of Int [...]
Regulators and standards organizations are increasingly requiring manufacturers [...]
There’s no question that quality risk management is becoming an indispensable to [...]
Combination products (CPs) have revolutionized drug delivery and patient care, b [...]
Three recent warning letters from the Center for Device and Radiological Health [...]
ABOUT
QUALITY AND COMPLIANCE SYSTEMS
FOR EVERY ENTERPRISE
SOLUTIONS
INDUSTRIES
CONTACT US
FOLLOW US
Sign up for the latest news and updates.
© Copyright 2000 - 2026, AssurX, Inc. All Rights Reserved.
